Avelas Biosciences Secures $550,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=521564d6-c295-424e-82e3-413d68eaca59 - Date
9/10/2014 - Company Name
Avelas Biosciences - Mailing Address
11099 N. Torrey Pines Road La Jolla, CA 92037 USA - Company Description
At Avelas Biosciences, our mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients. - Website
http://www.avelasbio.com - Transaction Type
Venture Equity - Transaction Amount
$550,000 - Transaction Round
Series B - Proceeds Purposes
The money will help to fund a first-in-man study of its proprietary fluorescent peptide that lights up cancerous cells in real time during breast cancer surgery. - M&A Terms
- Venture Investor
